CSS
SPRB

Cubist Systematic Strategies’s Spruce Biosciences SPRB Stock Holding History

Cubist Systematic Strategies’s Portfolio SPRB Stock Details SPRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-176
Closed -$27K – 4614
2022
Q1 		$27K Sell
176
-365
-67% -$67.9K ﹤0.01% 3456
2021
Q4 		$181K Buy
+541
New +$161K ﹤0.01% 3063

Other funds holding SPRB

NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
RVM
RiverVest Venture Management St. Louis, Missouri $6.84M AUM 7.71% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Cubist Systematic Strategies's SPRB Position: Q2 2022 in Review

Cubist Systematic Strategies sold out of Spruce Biosciences (SPRB) in Q2 2022, closing a stake of 176 shares — an estimated $27K sold.

Cubist Systematic Strategies first reported a position in SPRB in Q4 2021 and held it in 2 quarters. The position peaked at $181K in Q4 2021. 36 funds tracked by Wall St. Rank hold SPRB as of Q2 2022.

  • Cubist Systematic Strategies reported no remaining Spruce Biosciences position as of Q2 2022 after selling out during the quarter.
  • Cubist Systematic Strategies sold 176 Spruce Biosciences shares in Q2 2022, an estimated $27K.
  • Cubist Systematic Strategies first reported a position in Spruce Biosciences in Q4 2021 and held it in 2 quarters.
  • Cubist Systematic Strategies's Spruce Biosciences position peaked at $181K in Q4 2021.
  • 36 funds tracked by Wall St. Rank held Spruce Biosciences as of Q2 2022.

Based on Cubist Systematic Strategies's 13F filing for Q2 2022, filed 15 Aug 2022.